Updates are available Correction dated 2019-08-28

Click to view Correction: https://doi.org/10.1038/s41392-019-0065-6

A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity

Crossref DOI link: https://doi.org/10.1038/sigtrans.2016.25

Published Online: 2016-11-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark